Jazz Pharmaceuticals plc

NASDAQ:JAZZ   3:59:55 PM EDT
158.66
-1.60 (-1.00%)
Earnings Announcements

Jazz Pharmaceuticals Q2 Diluted Earnings Per Share 0.55 USD Versus 6.11 USD Loss Year Ago

Published: 08/03/2022 21:52 GMT
Jazz Pharmaceuticals plc (JAZZ) - Q2 Diluted Earnings per Share 0.55 USD Versus 6.11 USD Loss Year Ago.
Q2 Revenue Rose 24 Percent to 932.9 Million Usd.
Revenue is expected to be $940.14 Million
Adjusted EPS is expected to be $4.66

Next Quarter Revenue Guidance is expected to be $961.15 Million
Next Quarter EPS Guidance is expected to be $4.61

More details on our Analysts Page.